Idiopathic Parkinson’s Disease Unmasked by Valproate-Induced Parkinsonism in a Patient With Vestibular Migraine

We report a case of idiopathic Parkinson's disease (PD) in a patient with vestibular migraine (VM), initially suspected to have valproate-induced Parkinsonism. Valproate was started at 200 mg/day and titrated to 1,000 mg/day over four months for headache control. Although valproate provided effective headache relief, neurological symptoms, including hand tremor, shoulder stiffness, drooling, and adiadochokinesis, emerged and persisted despite discontinuation of the drug. Subsequent imaging studies, including dopamine transporter-single-photon emission computed tomography and 123I-meta-iodobenzylguanidine myocardial scintigraphy, confirmed the diagnosis of PD by the neurology department. This case highlights the need for careful monitoring of neurological signs during and after valproate therapy in VM patients, as latent PD may be unmasked.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-09-12
DOI
https://doi.org/10.7759/cureus.92131
Primary Topic
Vestibular and auditory disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Idiopathic Parkinson’s Disease Unmasked by Valproate-Induced Parkinsonism in a Patient With Vestibular Migraine

Teru Kamogashira
Cureus
Vestibular and auditory disorders
article

Idiopathic Parkinson’s Disease Unmasked by Valproate-Induced Parkinsonism in a Patient With Vestibular Migraine

Teru Kamogashira
article en

Abstract

We report a case of idiopathic Parkinson's disease (PD) in a patient with vestibular migraine (VM), initially suspected to have valproate-induced Parkinsonism. Valproate was started at 200 mg/day and titrated to 1,000 mg/day over four months for headache control. Although valproate provided effective headache relief, neurological symptoms, including hand tremor, shoulder stiffness, drooling, and adiadochokinesis, emerged and persisted despite discontinuation of the drug. Subsequent imaging studies, including dopamine transporter-single-photon emission computed tomography and 123I-meta-iodobenzylguanidine myocardial scintigraphy, confirmed the diagnosis of PD by the neurology department. This case highlights the need for careful monitoring of neurological signs during and after valproate therapy in VM patients, as latent PD may be unmasked.

CureusVol. 17(9)
University of Tokyo Hospital (JP)
Openalex Percentile: Top 68%
Vestibular and auditory disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.